Evidence has shown that the inactivation of HRK in prostate cancer constitutes a critical component in decreased apoptosis of tumour cells, whereas HRK-mediated mitochondrial dysfunction contributes to enhanced apoptosis in human malignancies [43]. The gene discussed is HRK; the disease is neoplasm.